A detailed history of Suvretta Capital Management, LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 7,069,627 shares of KURA stock, worth $120 Million. This represents 6.08% of its overall portfolio holdings.

Number of Shares
7,069,627
Previous 7,069,627 -0.0%
Holding current value
$120 Million
Previous $151 Million 3.47%
% of portfolio
6.08%
Previous 6.46%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.42 - $23.53 $1.66 Million - $2.9 Million
123,397 Added 1.78%
7,069,627 $151 Million
Q4 2023

Feb 14, 2024

SELL
$7.58 - $14.38 $2.95 Million - $5.6 Million
-389,615 Reduced 5.31%
6,946,230 $99.9 Million
Q3 2023

Nov 14, 2023

BUY
$8.44 - $11.86 $2.59 Million - $3.65 Million
307,403 Added 4.37%
7,335,845 $66.9 Million
Q2 2023

Aug 14, 2023

BUY
$9.62 - $13.99 $4.38 Million - $6.37 Million
455,107 Added 6.92%
7,028,442 $74.4 Million
Q1 2023

May 15, 2023

BUY
$10.71 - $14.6 $2.1 Million - $2.87 Million
196,520 Added 3.08%
6,573,335 $80.4 Million
Q4 2022

Feb 14, 2023

BUY
$11.23 - $16.9 $26 Million - $39.1 Million
2,313,687 Added 56.94%
6,376,815 $79.1 Million
Q3 2022

Nov 14, 2022

BUY
$12.01 - $19.45 $553,997 - $897,189
46,128 Added 1.15%
4,063,128 $55.5 Million
Q2 2022

Aug 15, 2022

BUY
$10.71 - $18.33 $1.33 Million - $2.27 Million
123,981 Added 3.18%
4,017,000 $73.6 Million
Q1 2022

May 16, 2022

BUY
$11.78 - $16.98 $3.78 Million - $5.44 Million
320,600 Added 8.97%
3,893,019 $62.6 Million
Q4 2021

Feb 14, 2022

BUY
$12.22 - $19.57 $13.6 Million - $21.8 Million
1,112,217 Added 45.21%
3,572,419 $50 Million
Q3 2021

Nov 15, 2021

BUY
$15.42 - $21.72 $12.4 Million - $17.4 Million
801,496 Added 48.32%
2,460,202 $46.1 Million
Q2 2021

Aug 16, 2021

BUY
$20.85 - $29.88 $19.3 Million - $27.7 Million
926,291 Added 126.47%
1,658,706 $34.6 Million
Q1 2021

May 17, 2021

BUY
$24.75 - $39.14 $11.4 Million - $18 Million
460,915 Added 169.77%
732,415 $20.7 Million
Q4 2020

Feb 16, 2021

BUY
$29.0 - $41.62 $4.42 Million - $6.35 Million
152,500 Added 128.15%
271,500 $8.87 Million
Q3 2020

Nov 16, 2020

BUY
$16.3 - $30.64 $1.94 Million - $3.65 Million
119,000 New
119,000 $3.65 Million

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $1.13B
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.